Literature DB >> 31755675

The role of survivin in the pathogenesis of endometriosis.

Bianca Bianco1,2, Carolina Filipchiuk3, Denise M Christofolini4, Caio P Barbosa4, Erik Montagna5.   

Abstract

INTRODUCTION: Endometriosis is a common, estrogen-dependent condition, defined as the presence of endometrial-like tissue outside of the uterus, associated with often chronic and inflammatory reaction. The association of endometriosis with cancer is unclear, although endometriosis and cancer present some molecular similarities. Survinin, encoded by the BIRC5 gene, is a protein that controls cell division, inhibits apoptosis and promotes angiogenesis. Here we aimed to summarize and to discuss the main findings of studies that addressed the involvement of survivin in the pathogenesis of endometriosis. EVIDENCE ACQUISITION: We conducted a comprehensive retrieval from electronic databases, included the MEDLINE, EMBASE, with no restrictions to time span. We used the search terms endometriosis and survivin or BIRC5 and collected all relevant studies to explore the association between endometriosis and surviving expression. EVIDENCE SYNTHESIS: A total of 21 studies included in the systematic review, comprising sample collected from 1263 women with endometriosis. Results showed the involvement of more than 60 genes and proteins evaluated in eutopic, ectopic, endometrial and ovarian endometriosis, as well as in several gynecological conditions compared to healthy controls.
CONCLUSIONS: The studies provided the basis for the involvement of survivin in the pathogenesis of the disease by several and independent pathways.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31755675     DOI: 10.23736/S0026-4806.19.06358-4

Source DB:  PubMed          Journal:  Minerva Med        ISSN: 0026-4806            Impact factor:   4.806


  1 in total

Review 1.  Endometriosis in para-aortic lymph node resembling a malignancy: a case report and literature review.

Authors:  Jinjin Li; Yingwei Liu; Kaiwen Du; Lin Xiao; Xinyue He; Fengqin Dai; Junying Tang
Journal:  BMC Womens Health       Date:  2022-04-05       Impact factor: 2.809

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.